Fierce Pharma June 21, 2024
In line with Africa’s goal of boosting local vaccine production, South African pharma company Biovac inked deals with Sanofi and EuBiologics to produce and distribute much-needed shots on the continent.
Through its Sanofi collaboration, Biovac will be the first African producer of inactivated polio vaccines (IPV). Sanofi will still produce drug material for the vaccines while Biovac will hold marketing authorizations and be responsible for late-stage formulation, filling, packaging and delivery of “millions of doses” to UNICEF for Gavi countries across Africa.
Sanofi has already supplied the world and UNICEF with more than 1.5 billion doses of its IPV vaccine through Gavi, the Vaccine Alliance. The company is a long-time partner of the Global Polio Eradication Initiative, which has immunized...
Today's Sponsors
Today's Sponsor